About P&T JournalContacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
Vice President, Group Publisher
Production: Mary Ellen Curry,
Director of Production Services
Circulation: Jackie Ott, Circulation Manager
Statement of Purpose
Guidelines for Authors
This special issue of P&T examines significant health problems facing the elderly.
Dr. Stefanacci discusses the demographics of aging and how P&T committees will need to address these changes.
Richard G. Stefanacci, DO, MGH, MBA, CMD
The use of certain medications can increase the risk of falling in older adults.
Elsaris Z. Riefkohl, PharmD, Heather L. Bieber, PharmD, Mark B. Burlingame, PharmD, BCPS, and David T. Lowenthal, MD, PhD
Some drug classes are more likely to cause involuntary weight loss in older people.
Michael Lewko, MD, Ayham Chamseddin, MD, Maged Zaky, MD, and Richard B. Birrer, MD, MPH
Lawrence M. Prescott, PhD
Extra vigilance is needed to ensure quality control in hospital pharmacies after hours.
Peter Teichman, MD, MPA, and Tonya Smith, PharmD
David Nash, MD, MBA, discusses RxHub, a company whose goal is to decrease medication errors in the delivery of prescription drugs.
David B. Nash, MD, MBA
Letter to the Editor
Matthew Grissinger, RPh, FASCP, emphasizes the need to ensure that patients receive clear instructions about their prescriptions.
Matthew Grissinger, RPh, FASCP
Stephen Barlas discusses how technology might help combat the growing problem of counterfeit drugs.
P&T presents the latest studies and information about FDA approvals, drug indications, and industry updates.
The authors review teriparatide (Forteo®) for the treatment of osteoporosis.
Marlon Honeywell, PharmD, Shay Phillips, PharmD, Evans Branch III, PharmD, Kim-Anh Vo, PharmD, Eardie I. Marks, PharmD, and Michael Thompson, BCNSP, PharmD
Health Care and Law
Robert I. Field, JD, MPH, PhD, discusses the changing role of the FDA.
Robert I. Field, JD, MPH, PhD